Why is $XENE stock down today?
Xenon Pharmaceuticals Inc · PHARMACEUTICAL PREPARATIONS
Why is $XENE down today?
The likely driver
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
GlobeNewswire Inc.·1:00 PM ETpositive
Price
$64.28
Move today
-0.5%
Volume vs avg
0.0x
Scanner alerts today
0
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.